Establishment Labs Appoints Dennis Condon to the Board of Directors
January 08, 2018 12:22 ET
|
Establishment Labs
NEW YORK, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product...
Establishment Labs and OBP Medical Announce Partnership to Deliver Innovative New Tool for Advanced Breast Aesthetics Procedures
November 29, 2017 14:35 ET
|
Establishment Labs
NEW YORK, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation,...
Establishment Labs Announces Positive Clinical Study Results for its Motiva Implants® Published in the Aesthetics Surgery Journal
September 14, 2017 08:00 ET
|
Establishment Labs
NEW YORK, Sept. 14, 2017 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation,...
Establishment Labs Announces $55 Million Combined Debt and Equity Financing
August 28, 2017 08:00 ET
|
Establishment Labs
NEW YORK, Aug. 28, 2017 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation,...
Establishment Labs Anuncia la certificación LEED Oro para su Casa Matriz en Costa Rica
August 10, 2017 08:00 ET
|
Establishment Labs
NUEVA YORK, Aug. 10, 2017 (GLOBE NEWSWIRE) -- Establishment Labs, una compañía global de dispositivos médicos enfocada en tecnologías estéticas con un fuerte énfasis en innovación y desarrollo,...
Establishment Labs Announces Leadership for Energy and Environmental Design (LEED) Gold Certification on its Headquarters in Costa Rica
August 10, 2017 08:00 ET
|
Establishment Labs
NEW YORK, Aug. 10, 2017 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation...
Establishment Labs presenta una solicitud de exención del dispositivo investigacional (EDI) para el ensayo clínico prospectivo de los Implantes Motiva®
August 08, 2017 15:35 ET
|
Establishment Labs
NUEVA YORK, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Establishment Labs, una empresa global de dispositivos médicos centrada en las tecnologías estéticas con un fuerte énfasis en el desarrollo de productos...
Establishment Labs Submits Investigational Device Exemption (IDE) Filing for Prospective Clinical Trial of Motiva Implants®
August 07, 2017 14:21 ET
|
Establishment Labs
NEW YORK, Aug. 07, 2017 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation,...
Establishment Labs obtiene el certificado normativo del Programa de Auditoria Única de Dispositivos Médicos (MDSAP)
July 26, 2017 05:48 ET
|
Establishment Labs
NUEVA YORK, July 26, 2017 (GLOBE NEWSWIRE) -- Establishment Labs, una compañía global de dispositivos médicos enfocada en las tecnologías estéticas con un importante énfasis en el desarrollo y la...
Establishment Labs Obtains Medical Device Single Audit Program (MDSAP) Regulatory Certification
July 25, 2017 11:00 ET
|
Establishment Labs
NEW YORK, July 25, 2017 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation...